Physician profile
Michael J Barnthouse
NPI 1265471098
$1,622.53
in general payments reported to CMS, 2019-2025
16 companies · $99.05 in 2025
The $99.05 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $315 · 2021: $475 · 2022: $204 · 2023: $85.39 · 2024: $306 · 2025: $99.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $477 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.71 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $807.41 | 2019-2022 | |
| Astellas Pharma US INC | $278.61 | 2023-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $103.30 | 2019-2021 | |
| Organon LLC | $70.26 | 2024 | |
| Exeltis, USA INC. | $53.19 | 2021-2024 | Slynd |
| Avion Pharmaceuticals | $52.09 | 2020-2022 | |
| Lilly USA, LLC | $42.73 | 2024-2025 | Zepbound, Mounjaro |
| Agile Therapeutics, INC. | $38.54 | 2021 | |
| Millicent US INC | $32.87 | 2024-2025 | Femlyv |
| Hologic Sales and Service, LLC | $26.45 | 2024 | Thinprep 2000 Processor, Aptima |
| Novo Nordisk INC | $25.75 | 2025 | Wegovy |
| Myovant Sciences INC. | $25.55 | 2021 | |
| Ascend Therapeutics US, LLC | $19.67 | 2021 | |
| Hologic INC | $15.98 | 2021 | |
| Virtus Pharmaceuticals LLC | $15.46 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Barnthouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.